OCULAR THERAPEUTIX, INC.
OCUL US67576A1007
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -65% | -62% | 60% | 78% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Kaiser Peter BDM |
11.03 USD |
9,653 Sold |
106,473 USD |
02/10/2025 | 02/10/2025 |
| Heier Jeffrey S. CSO |
11.04 USD |
10,502 Sold |
115,942 USD |
02/10/2025 | 02/10/2025 |
| Notman Donald O |
12.43 USD |
1,066 Sold |
13,250 USD |
02/09/2025 | 02/09/2025 |
| Heier Jeffrey S. CSO |
12.04 USD |
3,063 Sold |
36,879 USD |
25/08/2025 | 25/08/2025 |
| Kaiser Peter BDM |
12.04 USD |
3,011 Sold |
36,252 USD |
25/08/2025 | 25/08/2025 |
| Heier Jeffrey S. CSO |
12.04 USD |
3,063 Sold |
36,879 USD |
25/08/2025 | 25/08/2025 |
| Nayak Sanjay SR OFF |
12.04 USD |
1,885 Sold |
22,695 USD |
25/08/2025 | 25/08/2025 |
| Dugel Pravin O |
12.04 USD |
21,494 Sold |
258,788 USD |
25/08/2025 | 25/08/2025 |
| Waheed Nadia CMO |
8.05 USD |
13,861 Sold |
111,581 USD |
02/06/2025 | 02/06/2025 |
| Waheed Nadia CMO |
8.05 USD |
13,861 Sold |
111,581 USD |
02/06/2025 | 02/06/2025 |